Profit Or Loss [Abstract]

Pharming Group N.V. - Filing #1859781

Concept	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	—	—	—	—	—	198,871,000 USD	—	—	—	212,174,000 USD	—	—	—	—	—
Other income	—	—	—	—	—	—	2,620,000 USD	—	—	—	1,829,000 USD	—	—	—	—	—
Profit (loss) from operating activities	—	—	—	—	—	—	13,561,000 USD	—	—	—	76,256,000 USD	—	—	—	—	—
Finance income	—	—	—	—	—	—	14,894,000 USD	—	—	—	715,000 USD	—	—	—	—	—
Finance costs	—	—	—	—	—	—	6,185,000 USD	—	—	—	33,308,000 USD	—	—	—	—	—
Profit (loss) before tax	—	—	—	—	—	—	23,078,000 USD	—	—	—	44,094,000 USD	—	—	—	—	—
Tax expense (income)	—	—	—	—	—	—	7,082,000 USD	—	—	—	6,348,000 USD	—	—	—	—	—
Profit (loss)	— USD	— USD	— USD	— USD	— USD	— USD	15,996,000 USD	15,996,000 USD	37,746,000 USD	— USD	37,746,000 USD	— USD	— USD	— USD	— USD	— USD
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share	—	—	—	—	—	—	0.025	—	—	—	0.058	—	—	—	—	—
Diluted earnings per share [abstract]
Diluted earnings (loss) per share	—	—	—	—	—	—	0.023	—	—	—	0.055	—	—	—	—	—